Close Menu

 

Harvard Bioscience Shares Plunge, Molecular Devices Up

With shares of Harvard Bioscience dropping 13 percent, and Bio-Rad falling 11 percent, the BioCommerce Week Index this week ended down for the third time in the last four weeks.

Harvard Bioscience has lost 19 percent of its market capitalization in the last two weeks while Bio-Rad saw a 9-percent gain last week reversed this week.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Nature News reports that researchers in Japan hope to soon test the use of reprogrammed stem cells to treat damaged corneas.

A new approach may help limit the number of fish that are mislabeled at markets or restaurants, according to New Scientist.

At Slate, the R Street Institute's Nila Bala discusses the privacy rights of suspects that genetic genealogy approaches in law enforcement bring up.

In PNAS this week: numerous mobile genetic elements contribute to Vibrio cholerae drug resistance, troponin I mutations in sudden infant deaths, and more.